| Disease associated variation - GWASdb |
| Chr | Pos | SNP ID(dbSNP 142) | Ref | Alt | Ori SNP ID | P-value | Drug Name | Drug Anno | GWAS Trait | HPO ID | DO ID | AA | Type | Trait or Drug |
|---|
| 1 | 92561392 | rs11166141 | A | G | rs11166141 | 0.0009675 | INFLIXIMAB|ADALIMUMAB|IMMUNOGLOBULIN G | TUMOR NECROSIS FACTOR-ALPHA|ANTIRHEUMATIC AGENTS|ANTIBODIES, MONOCLONAL, HUMANIZED|TNFR-FC FUSION PROTEIN|ANTIBODIES, MONOCLONAL|RECEPTORS, TUMOR NECROSIS FACTOR | Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) | HPOID:0001370 | DOID:7148 | A | intron | GWASdb_drug |
| 1 | 92561392 | rs11166141 | A | G | rs11166141 | 9.68E-04 | LEUCOVORIN|METHOTREXATE | SLCO1B1 PROTEIN, HUMAN|ORGANIC ANION TRANSPORTERS | Methotrexate clearance (acute lymphoblastic leukemia) | HPOID:0006721 | DOID:9952|DOID:12603 | A | intron | GWASdb_drug |
| 1 | 92563120 | rs6684317 | C | G | rs6684317 | 0.0009685 | INFLIXIMAB|ADALIMUMAB|IMMUNOGLOBULIN G | TUMOR NECROSIS FACTOR-ALPHA|ANTIRHEUMATIC AGENTS|ANTIBODIES, MONOCLONAL, HUMANIZED|TNFR-FC FUSION PROTEIN|ANTIBODIES, MONOCLONAL|RECEPTORS, TUMOR NECROSIS FACTOR | Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) | HPOID:0001370 | DOID:7148 | C | intron | GWASdb_drug |
| 1 | 92563120 | rs6684317 | C | G | rs6684317 | 9.69E-04 | LEUCOVORIN|METHOTREXATE | SLCO1B1 PROTEIN, HUMAN|ORGANIC ANION TRANSPORTERS | Methotrexate clearance (acute lymphoblastic leukemia) | HPOID:0006721 | DOID:9952|DOID:12603 | C | intron | GWASdb_drug |
| 1 | 92563373 | rs11166144 | G | A | rs11166144 | 0.0009676 | INFLIXIMAB|ADALIMUMAB|IMMUNOGLOBULIN G | TUMOR NECROSIS FACTOR-ALPHA|ANTIRHEUMATIC AGENTS|ANTIBODIES, MONOCLONAL, HUMANIZED|TNFR-FC FUSION PROTEIN|ANTIBODIES, MONOCLONAL|RECEPTORS, TUMOR NECROSIS FACTOR | Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) | HPOID:0001370 | DOID:7148 | G | intron | GWASdb_drug |
| 1 | 92563373 | rs11166144 | G | A | rs11166144 | 9.68E-04 | LEUCOVORIN|METHOTREXATE | SLCO1B1 PROTEIN, HUMAN|ORGANIC ANION TRANSPORTERS | Methotrexate clearance (acute lymphoblastic leukemia) | HPOID:0006721 | DOID:9952|DOID:12603 | G | intron | GWASdb_drug |
| 1 | 92564147 | rs2128646 | A | T | rs2128646 | 0.0009677 | INFLIXIMAB|ADALIMUMAB|IMMUNOGLOBULIN G | TUMOR NECROSIS FACTOR-ALPHA|ANTIRHEUMATIC AGENTS|ANTIBODIES, MONOCLONAL, HUMANIZED|TNFR-FC FUSION PROTEIN|ANTIBODIES, MONOCLONAL|RECEPTORS, TUMOR NECROSIS FACTOR | Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) | HPOID:0001370 | DOID:7148 | T | intron | GWASdb_drug |
| 1 | 92564147 | rs2128646 | A | T | rs2128646 | 9.68E-04 | LEUCOVORIN|METHOTREXATE | SLCO1B1 PROTEIN, HUMAN|ORGANIC ANION TRANSPORTERS | Methotrexate clearance (acute lymphoblastic leukemia) | HPOID:0006721 | DOID:9952|DOID:12603 | T | intron | GWASdb_drug |
| 1 | 92564644 | rs2128645 | C | T | rs2128645 | 0.0009212 | INFLIXIMAB|ADALIMUMAB|IMMUNOGLOBULIN G | TUMOR NECROSIS FACTOR-ALPHA|ANTIRHEUMATIC AGENTS|ANTIBODIES, MONOCLONAL, HUMANIZED|TNFR-FC FUSION PROTEIN|ANTIBODIES, MONOCLONAL|RECEPTORS, TUMOR NECROSIS FACTOR | Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) | HPOID:0001370 | DOID:7148 | C | intron | GWASdb_drug |
| 1 | 92564644 | rs2128645 | C | T | rs2128645 | 9.21E-04 | LEUCOVORIN|METHOTREXATE | SLCO1B1 PROTEIN, HUMAN|ORGANIC ANION TRANSPORTERS | Methotrexate clearance (acute lymphoblastic leukemia) | HPOID:0006721 | DOID:9952|DOID:12603 | C | intron | GWASdb_drug |
| 1 | 92571295 | rs981583 | T | A | rs981583 | 0.000658 | INFLIXIMAB|ADALIMUMAB|IMMUNOGLOBULIN G | TUMOR NECROSIS FACTOR-ALPHA|ANTIRHEUMATIC AGENTS|ANTIBODIES, MONOCLONAL, HUMANIZED|TNFR-FC FUSION PROTEIN|ANTIBODIES, MONOCLONAL|RECEPTORS, TUMOR NECROSIS FACTOR | Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) | HPOID:0001370 | DOID:7148 | A | intron | GWASdb_drug |
| 1 | 92571295 | rs981583 | T | A | rs981583 | 6.58E-04 | LEUCOVORIN|METHOTREXATE | SLCO1B1 PROTEIN, HUMAN|ORGANIC ANION TRANSPORTERS | Methotrexate clearance (acute lymphoblastic leukemia) | HPOID:0006721 | DOID:9952|DOID:12603 | A | intron | GWASdb_drug |
| 1 | 92572296 | rs4658290 | C | G | rs4658290 | 0.0006583 | INFLIXIMAB|ADALIMUMAB|IMMUNOGLOBULIN G | TUMOR NECROSIS FACTOR-ALPHA|ANTIRHEUMATIC AGENTS|ANTIBODIES, MONOCLONAL, HUMANIZED|TNFR-FC FUSION PROTEIN|ANTIBODIES, MONOCLONAL|RECEPTORS, TUMOR NECROSIS FACTOR | Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) | HPOID:0001370 | DOID:7148 | C | intron | GWASdb_drug |
| 1 | 92572296 | rs4658290 | C | G | rs4658290 | 6.58E-04 | LEUCOVORIN|METHOTREXATE | SLCO1B1 PROTEIN, HUMAN|ORGANIC ANION TRANSPORTERS | Methotrexate clearance (acute lymphoblastic leukemia) | HPOID:0006721 | DOID:9952|DOID:12603 | C | intron | GWASdb_drug |
| 1 | 92579675 | rs10875204 | G | A | rs10875204 | 0.0005029 | INFLIXIMAB|ADALIMUMAB|IMMUNOGLOBULIN G | TUMOR NECROSIS FACTOR-ALPHA|ANTIRHEUMATIC AGENTS|ANTIBODIES, MONOCLONAL, HUMANIZED|TNFR-FC FUSION PROTEIN|ANTIBODIES, MONOCLONAL|RECEPTORS, TUMOR NECROSIS FACTOR | Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) | HPOID:0001370 | DOID:7148 | G | intron | GWASdb_drug |
| 1 | 92579675 | rs10875204 | G | A | rs10875204 | 5.03E-04 | LEUCOVORIN|METHOTREXATE | SLCO1B1 PROTEIN, HUMAN|ORGANIC ANION TRANSPORTERS | Methotrexate clearance (acute lymphoblastic leukemia) | HPOID:0006721 | DOID:9952|DOID:12603 | G | intron | GWASdb_drug |
| 1 | 92584519 | rs7533077 | A | G | rs7533077 | 0.0005404 | INFLIXIMAB|ADALIMUMAB|IMMUNOGLOBULIN G | TUMOR NECROSIS FACTOR-ALPHA|ANTIRHEUMATIC AGENTS|ANTIBODIES, MONOCLONAL, HUMANIZED|TNFR-FC FUSION PROTEIN|ANTIBODIES, MONOCLONAL|RECEPTORS, TUMOR NECROSIS FACTOR | Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) | HPOID:0001370 | DOID:7148 | A,G | intron | GWASdb_drug |
| 1 | 92584519 | rs7533077 | A | G | rs7533077 | 5.40E-04 | LEUCOVORIN|METHOTREXATE | SLCO1B1 PROTEIN, HUMAN|ORGANIC ANION TRANSPORTERS | Methotrexate clearance (acute lymphoblastic leukemia) | HPOID:0006721 | DOID:9952|DOID:12603 | A,G | intron | GWASdb_drug |
| 1 | 92587233 | rs7542358 | A | G | rs7542358 | 0.0002718 | INFLIXIMAB|ADALIMUMAB|IMMUNOGLOBULIN G | TUMOR NECROSIS FACTOR-ALPHA|ANTIRHEUMATIC AGENTS|ANTIBODIES, MONOCLONAL, HUMANIZED|TNFR-FC FUSION PROTEIN|ANTIBODIES, MONOCLONAL|RECEPTORS, TUMOR NECROSIS FACTOR | Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) | HPOID:0001370 | DOID:7148 | A | intron | GWASdb_drug |
| 1 | 92587233 | rs7542358 | A | G | rs7542358 | 2.72E-04 | LEUCOVORIN|METHOTREXATE | SLCO1B1 PROTEIN, HUMAN|ORGANIC ANION TRANSPORTERS | Methotrexate clearance (acute lymphoblastic leukemia) | HPOID:0006721 | DOID:9952|DOID:12603 | A | intron | GWASdb_drug |
| 1 | 92587270 | rs7542373 | A | G | rs7542373 | 0.0004574 | INFLIXIMAB|ADALIMUMAB|IMMUNOGLOBULIN G | TUMOR NECROSIS FACTOR-ALPHA|ANTIRHEUMATIC AGENTS|ANTIBODIES, MONOCLONAL, HUMANIZED|TNFR-FC FUSION PROTEIN|ANTIBODIES, MONOCLONAL|RECEPTORS, TUMOR NECROSIS FACTOR | Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) | HPOID:0001370 | DOID:7148 | G | intron | GWASdb_drug |
| 1 | 92587270 | rs7542373 | A | G | rs7542373 | 4.57E-04 | LEUCOVORIN|METHOTREXATE | SLCO1B1 PROTEIN, HUMAN|ORGANIC ANION TRANSPORTERS | Methotrexate clearance (acute lymphoblastic leukemia) | HPOID:0006721 | DOID:9952|DOID:12603 | G | intron | GWASdb_drug |
| 1 | 92587687 | rs2391114 | G | A | rs2391114 | 0.000419 | INFLIXIMAB|ADALIMUMAB|IMMUNOGLOBULIN G | TUMOR NECROSIS FACTOR-ALPHA|ANTIRHEUMATIC AGENTS|ANTIBODIES, MONOCLONAL, HUMANIZED|TNFR-FC FUSION PROTEIN|ANTIBODIES, MONOCLONAL|RECEPTORS, TUMOR NECROSIS FACTOR | Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) | HPOID:0001370 | DOID:7148 | A | intron | GWASdb_drug |
| 1 | 92587687 | rs2391114 | G | A | rs2391114 | 4.19E-04 | LEUCOVORIN|METHOTREXATE | SLCO1B1 PROTEIN, HUMAN|ORGANIC ANION TRANSPORTERS | Methotrexate clearance (acute lymphoblastic leukemia) | HPOID:0006721 | DOID:9952|DOID:12603 | A | intron | GWASdb_drug |
| 1 | 92588993 | rs6604080 | T | A | rs6604080 | 0.0004021 | INFLIXIMAB|ADALIMUMAB|IMMUNOGLOBULIN G | TUMOR NECROSIS FACTOR-ALPHA|ANTIRHEUMATIC AGENTS|ANTIBODIES, MONOCLONAL, HUMANIZED|TNFR-FC FUSION PROTEIN|ANTIBODIES, MONOCLONAL|RECEPTORS, TUMOR NECROSIS FACTOR | Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) | HPOID:0001370 | DOID:7148 | A | intron | GWASdb_drug |
| 1 | 92588993 | rs6604080 | T | A | rs6604080 | 4.02E-04 | LEUCOVORIN|METHOTREXATE | SLCO1B1 PROTEIN, HUMAN|ORGANIC ANION TRANSPORTERS | Methotrexate clearance (acute lymphoblastic leukemia) | HPOID:0006721 | DOID:9952|DOID:12603 | A | intron | GWASdb_drug |
| 1 | 92589511 | rs3851273 | G | A | rs3851273 | 0.0003817 | INFLIXIMAB|ADALIMUMAB|IMMUNOGLOBULIN G | TUMOR NECROSIS FACTOR-ALPHA|ANTIRHEUMATIC AGENTS|ANTIBODIES, MONOCLONAL, HUMANIZED|TNFR-FC FUSION PROTEIN|ANTIBODIES, MONOCLONAL|RECEPTORS, TUMOR NECROSIS FACTOR | Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) | HPOID:0001370 | DOID:7148 | C | intron | GWASdb_drug |
| 1 | 92589511 | rs3851273 | G | A | rs3851273 | 3.82E-04 | LEUCOVORIN|METHOTREXATE | SLCO1B1 PROTEIN, HUMAN|ORGANIC ANION TRANSPORTERS | Methotrexate clearance (acute lymphoblastic leukemia) | HPOID:0006721 | DOID:9952|DOID:12603 | C | intron | GWASdb_drug |
| 1 | 92590826 | rs10875209 | A | G | rs10875209 | 0.0003662 | INFLIXIMAB|ADALIMUMAB|IMMUNOGLOBULIN G | TUMOR NECROSIS FACTOR-ALPHA|ANTIRHEUMATIC AGENTS|ANTIBODIES, MONOCLONAL, HUMANIZED|TNFR-FC FUSION PROTEIN|ANTIBODIES, MONOCLONAL|RECEPTORS, TUMOR NECROSIS FACTOR | Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) | HPOID:0001370 | DOID:7148 | A | intron | GWASdb_drug |
| 1 | 92590826 | rs10875209 | A | G | rs10875209 | 3.66E-04 | LEUCOVORIN|METHOTREXATE | SLCO1B1 PROTEIN, HUMAN|ORGANIC ANION TRANSPORTERS | Methotrexate clearance (acute lymphoblastic leukemia) | HPOID:0006721 | DOID:9952|DOID:12603 | A | intron | GWASdb_drug |
| 1 | 92591916 | rs3851272 | G | A | rs3851272 | 0.0003492 | INFLIXIMAB|ADALIMUMAB|IMMUNOGLOBULIN G | TUMOR NECROSIS FACTOR-ALPHA|ANTIRHEUMATIC AGENTS|ANTIBODIES, MONOCLONAL, HUMANIZED|TNFR-FC FUSION PROTEIN|ANTIBODIES, MONOCLONAL|RECEPTORS, TUMOR NECROSIS FACTOR | Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) | HPOID:0001370 | DOID:7148 | G | intron | GWASdb_drug |
| 1 | 92591916 | rs3851272 | G | A | rs3851272 | 3.49E-04 | LEUCOVORIN|METHOTREXATE | SLCO1B1 PROTEIN, HUMAN|ORGANIC ANION TRANSPORTERS | Methotrexate clearance (acute lymphoblastic leukemia) | HPOID:0006721 | DOID:9952|DOID:12603 | G | intron | GWASdb_drug |
| 1 | 92592222 | rs3851271 | T | C | rs3851271 | 0.0003508 | INFLIXIMAB|ADALIMUMAB|IMMUNOGLOBULIN G | TUMOR NECROSIS FACTOR-ALPHA|ANTIRHEUMATIC AGENTS|ANTIBODIES, MONOCLONAL, HUMANIZED|TNFR-FC FUSION PROTEIN|ANTIBODIES, MONOCLONAL|RECEPTORS, TUMOR NECROSIS FACTOR | Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) | HPOID:0001370 | DOID:7148 | T | intron | GWASdb_drug |
| 1 | 92592222 | rs3851271 | T | C | rs3851271 | 3.51E-04 | LEUCOVORIN|METHOTREXATE | SLCO1B1 PROTEIN, HUMAN|ORGANIC ANION TRANSPORTERS | Methotrexate clearance (acute lymphoblastic leukemia) | HPOID:0006721 | DOID:9952|DOID:12603 | T | intron | GWASdb_drug |
| 1 | 92597344 | rs10875214 | G | C | rs10875214 | 0.0003533 | INFLIXIMAB|ADALIMUMAB|IMMUNOGLOBULIN G | TUMOR NECROSIS FACTOR-ALPHA|ANTIRHEUMATIC AGENTS|ANTIBODIES, MONOCLONAL, HUMANIZED|TNFR-FC FUSION PROTEIN|ANTIBODIES, MONOCLONAL|RECEPTORS, TUMOR NECROSIS FACTOR | Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) | HPOID:0001370 | DOID:7148 | C | intron | GWASdb_drug |
| 1 | 92597344 | rs10875214 | G | C | rs10875214 | 3.53E-04 | LEUCOVORIN|METHOTREXATE | SLCO1B1 PROTEIN, HUMAN|ORGANIC ANION TRANSPORTERS | Methotrexate clearance (acute lymphoblastic leukemia) | HPOID:0006721 | DOID:9952|DOID:12603 | C | intron | GWASdb_drug |
| 1 | 92598705 | rs1157469 | T | C | rs1157469 | 0.0003681 | INFLIXIMAB|ADALIMUMAB|IMMUNOGLOBULIN G | TUMOR NECROSIS FACTOR-ALPHA|ANTIRHEUMATIC AGENTS|ANTIBODIES, MONOCLONAL, HUMANIZED|TNFR-FC FUSION PROTEIN|ANTIBODIES, MONOCLONAL|RECEPTORS, TUMOR NECROSIS FACTOR | Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) | HPOID:0001370 | DOID:7148 | T | intron | GWASdb_drug |
| 1 | 92598705 | rs1157469 | T | C | rs1157469 | 3.68E-04 | LEUCOVORIN|METHOTREXATE | SLCO1B1 PROTEIN, HUMAN|ORGANIC ANION TRANSPORTERS | Methotrexate clearance (acute lymphoblastic leukemia) | HPOID:0006721 | DOID:9952|DOID:12603 | T | intron | GWASdb_drug |
| 1 | 92598807 | rs1157470 | T | A | rs1157470 | 0.0003574 | INFLIXIMAB|ADALIMUMAB|IMMUNOGLOBULIN G | TUMOR NECROSIS FACTOR-ALPHA|ANTIRHEUMATIC AGENTS|ANTIBODIES, MONOCLONAL, HUMANIZED|TNFR-FC FUSION PROTEIN|ANTIBODIES, MONOCLONAL|RECEPTORS, TUMOR NECROSIS FACTOR | Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) | HPOID:0001370 | DOID:7148 | A | intron | GWASdb_drug |
| 1 | 92598807 | rs1157470 | T | A | rs1157470 | 3.57E-04 | LEUCOVORIN|METHOTREXATE | SLCO1B1 PROTEIN, HUMAN|ORGANIC ANION TRANSPORTERS | Methotrexate clearance (acute lymphoblastic leukemia) | HPOID:0006721 | DOID:9952|DOID:12603 | A | intron | GWASdb_drug |
| 1 | 92600183 | rs1982720 | C | G | rs1982720 | 0.0003529 | INFLIXIMAB|ADALIMUMAB|IMMUNOGLOBULIN G | TUMOR NECROSIS FACTOR-ALPHA|ANTIRHEUMATIC AGENTS|ANTIBODIES, MONOCLONAL, HUMANIZED|TNFR-FC FUSION PROTEIN|ANTIBODIES, MONOCLONAL|RECEPTORS, TUMOR NECROSIS FACTOR | Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) | HPOID:0001370 | DOID:7148 | G | intron | GWASdb_drug |
| 1 | 92600183 | rs1982720 | C | G | rs1982720 | 3.53E-04 | LEUCOVORIN|METHOTREXATE | SLCO1B1 PROTEIN, HUMAN|ORGANIC ANION TRANSPORTERS | Methotrexate clearance (acute lymphoblastic leukemia) | HPOID:0006721 | DOID:9952|DOID:12603 | G | intron | GWASdb_drug |
| 1 | 92602477 | rs12119246 | A | G | rs12119246 | 0.0002028 | INFLIXIMAB|ADALIMUMAB|IMMUNOGLOBULIN G | TUMOR NECROSIS FACTOR-ALPHA|ANTIRHEUMATIC AGENTS|ANTIBODIES, MONOCLONAL, HUMANIZED|TNFR-FC FUSION PROTEIN|ANTIBODIES, MONOCLONAL|RECEPTORS, TUMOR NECROSIS FACTOR | Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) | HPOID:0001370 | DOID:7148 | A | intron | GWASdb_drug |
| 1 | 92602477 | rs12119246 | A | G | rs12119246 | 2.03E-04 | LEUCOVORIN|METHOTREXATE | SLCO1B1 PROTEIN, HUMAN|ORGANIC ANION TRANSPORTERS | Methotrexate clearance (acute lymphoblastic leukemia) | HPOID:0006721 | DOID:9952|DOID:12603 | A | intron | GWASdb_drug |
| 1 | 92604320 | rs2839877 | G | T | rs2839877 | 0.0003596 | INFLIXIMAB|ADALIMUMAB|IMMUNOGLOBULIN G | TUMOR NECROSIS FACTOR-ALPHA|ANTIRHEUMATIC AGENTS|ANTIBODIES, MONOCLONAL, HUMANIZED|TNFR-FC FUSION PROTEIN|ANTIBODIES, MONOCLONAL|RECEPTORS, TUMOR NECROSIS FACTOR | Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) | HPOID:0001370 | DOID:7148 | G | intron | GWASdb_drug |
| 1 | 92604320 | rs2839877 | G | T | rs2839877 | 3.60E-04 | LEUCOVORIN|METHOTREXATE | SLCO1B1 PROTEIN, HUMAN|ORGANIC ANION TRANSPORTERS | Methotrexate clearance (acute lymphoblastic leukemia) | HPOID:0006721 | DOID:9952|DOID:12603 | G | intron | GWASdb_drug |
| 1 | 92608029 | rs2893200 | G | A | rs2893200 | 0.00038 | INFLIXIMAB|ADALIMUMAB|IMMUNOGLOBULIN G | TUMOR NECROSIS FACTOR-ALPHA|ANTIRHEUMATIC AGENTS|ANTIBODIES, MONOCLONAL, HUMANIZED|TNFR-FC FUSION PROTEIN|ANTIBODIES, MONOCLONAL|RECEPTORS, TUMOR NECROSIS FACTOR | Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) | HPOID:0001370 | DOID:7148 | G | intron | GWASdb_drug |
| 1 | 92608029 | rs2893200 | G | A | rs2893200 | 3.80E-04 | LEUCOVORIN|METHOTREXATE | SLCO1B1 PROTEIN, HUMAN|ORGANIC ANION TRANSPORTERS | Methotrexate clearance (acute lymphoblastic leukemia) | HPOID:0006721 | DOID:9952|DOID:12603 | G | intron | GWASdb_drug |
| 1 | 92554283 | rs34856868 | G | A | rs34856868 | 2.00E-06 | | | Obesity-related traits | HPOID:0001513 | DOID:9970 | C | missense | GWASdb_trait |
| 1 | 92561392 | rs11166141 | A | G | rs11166141 | 9.68E-04 | | | Methotrexate clearance (acute lymphoblastic leukemia) | HPOID:0006721 | DOID:9952|DOID:12603 | A | intron | GWASdb_trait |
| 1 | 92563120 | rs6684317 | C | G | rs6684317 | 9.69E-04 | | | Methotrexate clearance (acute lymphoblastic leukemia) | HPOID:0006721 | DOID:9952|DOID:12603 | C | intron | GWASdb_trait |
| 1 | 92563373 | rs11166144 | G | A | rs11166144 | 9.68E-04 | | | Methotrexate clearance (acute lymphoblastic leukemia) | HPOID:0006721 | DOID:9952|DOID:12603 | G | intron | GWASdb_trait |
| 1 | 92564147 | rs2128646 | A | T | rs2128646 | 9.68E-04 | | | Methotrexate clearance (acute lymphoblastic leukemia) | HPOID:0006721 | DOID:9952|DOID:12603 | T | intron | GWASdb_trait |
| 1 | 92564644 | rs2128645 | C | T | rs2128645 | 9.21E-04 | | | Methotrexate clearance (acute lymphoblastic leukemia) | HPOID:0006721 | DOID:9952|DOID:12603 | C | intron | GWASdb_trait |
| 1 | 92571295 | rs981583 | T | A | rs981583 | 0.000658 | | | Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) | HPOID:0001370 | DOID:7148 | A | intron | GWASdb_trait |
| 1 | 92571295 | rs981583 | T | A | rs981583 | 6.58E-04 | | | Methotrexate clearance (acute lymphoblastic leukemia) | HPOID:0006721 | DOID:9952|DOID:12603 | A | intron | GWASdb_trait |
| 1 | 92572296 | rs4658290 | C | G | rs4658290 | 0.0006583 | | | Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) | HPOID:0001370 | DOID:7148 | C | intron | GWASdb_trait |
| 1 | 92572296 | rs4658290 | C | G | rs4658290 | 6.58E-04 | | | Methotrexate clearance (acute lymphoblastic leukemia) | HPOID:0006721 | DOID:9952|DOID:12603 | C | intron | GWASdb_trait |
| 1 | 92579675 | rs10875204 | G | A | rs10875204 | 0.0005029 | | | Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) | HPOID:0001370 | DOID:7148 | G | intron | GWASdb_trait |
| 1 | 92579675 | rs10875204 | G | A | rs10875204 | 5.03E-04 | | | Methotrexate clearance (acute lymphoblastic leukemia) | HPOID:0006721 | DOID:9952|DOID:12603 | G | intron | GWASdb_trait |
| 1 | 92584519 | rs7533077 | A | G | rs7533077 | 0.0005404 | | | Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) | HPOID:0001370 | DOID:7148 | A,G | intron | GWASdb_trait |
| 1 | 92584519 | rs7533077 | A | G | rs7533077 | 5.40E-04 | | | Methotrexate clearance (acute lymphoblastic leukemia) | HPOID:0006721 | DOID:9952|DOID:12603 | A,G | intron | GWASdb_trait |
| 1 | 92587233 | rs7542358 | A | G | rs7542358 | 0.0002718 | | | Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) | HPOID:0001370 | DOID:7148 | A | intron | GWASdb_trait |
| 1 | 92587233 | rs7542358 | A | G | rs7542358 | 2.72E-04 | | | Methotrexate clearance (acute lymphoblastic leukemia) | HPOID:0006721 | DOID:9952|DOID:12603 | A | intron | GWASdb_trait |
| 1 | 92587270 | rs7542373 | A | G | rs7542373 | 0.0004574 | | | Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) | HPOID:0001370 | DOID:7148 | G | intron | GWASdb_trait |
| 1 | 92587270 | rs7542373 | A | G | rs7542373 | 4.57E-04 | | | Methotrexate clearance (acute lymphoblastic leukemia) | HPOID:0006721 | DOID:9952|DOID:12603 | G | intron | GWASdb_trait |
| 1 | 92587687 | rs2391114 | G | A | rs2391114 | 0.000419 | | | Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) | HPOID:0001370 | DOID:7148 | A | intron | GWASdb_trait |
| 1 | 92587687 | rs2391114 | G | A | rs2391114 | 4.19E-04 | | | Methotrexate clearance (acute lymphoblastic leukemia) | HPOID:0006721 | DOID:9952|DOID:12603 | A | intron | GWASdb_trait |
| 1 | 92588993 | rs6604080 | T | A | rs6604080 | 0.0004021 | | | Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) | HPOID:0001370 | DOID:7148 | A | intron | GWASdb_trait |
| 1 | 92588993 | rs6604080 | T | A | rs6604080 | 4.02E-04 | | | Methotrexate clearance (acute lymphoblastic leukemia) | HPOID:0006721 | DOID:9952|DOID:12603 | A | intron | GWASdb_trait |
| 1 | 92589511 | rs3851273 | G | A | rs3851273 | 0.0003817 | | | Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) | HPOID:0001370 | DOID:7148 | C | intron | GWASdb_trait |
| 1 | 92589511 | rs3851273 | G | A | rs3851273 | 3.82E-04 | | | Methotrexate clearance (acute lymphoblastic leukemia) | HPOID:0006721 | DOID:9952|DOID:12603 | C | intron | GWASdb_trait |
| 1 | 92590826 | rs10875209 | A | G | rs10875209 | 0.0003662 | | | Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) | HPOID:0001370 | DOID:7148 | A | intron | GWASdb_trait |
| 1 | 92590826 | rs10875209 | A | G | rs10875209 | 3.66E-04 | | | Methotrexate clearance (acute lymphoblastic leukemia) | HPOID:0006721 | DOID:9952|DOID:12603 | A | intron | GWASdb_trait |
| 1 | 92591916 | rs3851272 | G | A | rs3851272 | 0.0003492 | | | Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) | HPOID:0001370 | DOID:7148 | G | intron | GWASdb_trait |
| 1 | 92591916 | rs3851272 | G | A | rs3851272 | 3.49E-04 | | | Methotrexate clearance (acute lymphoblastic leukemia) | HPOID:0006721 | DOID:9952|DOID:12603 | G | intron | GWASdb_trait |
| 1 | 92592222 | rs3851271 | T | C | rs3851271 | 0.0003508 | | | Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) | HPOID:0001370 | DOID:7148 | T | intron | GWASdb_trait |
| 1 | 92592222 | rs3851271 | T | C | rs3851271 | 3.51E-04 | | | Methotrexate clearance (acute lymphoblastic leukemia) | HPOID:0006721 | DOID:9952|DOID:12603 | T | intron | GWASdb_trait |
| 1 | 92597344 | rs10875214 | G | C | rs10875214 | 0.0003533 | | | Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) | HPOID:0001370 | DOID:7148 | C | intron | GWASdb_trait |
| 1 | 92597344 | rs10875214 | G | C | rs10875214 | 3.53E-04 | | | Methotrexate clearance (acute lymphoblastic leukemia) | HPOID:0006721 | DOID:9952|DOID:12603 | C | intron | GWASdb_trait |
| 1 | 92598705 | rs1157469 | T | C | rs1157469 | 0.0003681 | | | Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) | HPOID:0001370 | DOID:7148 | T | intron | GWASdb_trait |
| 1 | 92598705 | rs1157469 | T | C | rs1157469 | 3.68E-04 | | | Methotrexate clearance (acute lymphoblastic leukemia) | HPOID:0006721 | DOID:9952|DOID:12603 | T | intron | GWASdb_trait |
| 1 | 92598807 | rs1157470 | T | A | rs1157470 | 0.0003574 | | | Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) | HPOID:0001370 | DOID:7148 | A | intron | GWASdb_trait |
| 1 | 92598807 | rs1157470 | T | A | rs1157470 | 3.57E-04 | | | Methotrexate clearance (acute lymphoblastic leukemia) | HPOID:0006721 | DOID:9952|DOID:12603 | A | intron | GWASdb_trait |
| 1 | 92600183 | rs1982720 | C | G | rs1982720 | 0.0003529 | | | Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) | HPOID:0001370 | DOID:7148 | G | intron | GWASdb_trait |
| 1 | 92600183 | rs1982720 | C | G | rs1982720 | 3.53E-04 | | | Methotrexate clearance (acute lymphoblastic leukemia) | HPOID:0006721 | DOID:9952|DOID:12603 | G | intron | GWASdb_trait |
| 1 | 92602477 | rs12119246 | A | G | rs12119246 | 0.0002028 | | | Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) | HPOID:0001370 | DOID:7148 | A | intron | GWASdb_trait |
| 1 | 92602477 | rs12119246 | A | G | rs12119246 | 2.03E-04 | | | Methotrexate clearance (acute lymphoblastic leukemia) | HPOID:0006721 | DOID:9952|DOID:12603 | A | intron | GWASdb_trait |
| 1 | 92604320 | rs2839877 | G | T | rs2839877 | 0.0003596 | | | Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) | HPOID:0001370 | DOID:7148 | G | intron | GWASdb_trait |
| 1 | 92604320 | rs2839877 | G | T | rs2839877 | 3.60E-04 | | | Methotrexate clearance (acute lymphoblastic leukemia) | HPOID:0006721 | DOID:9952|DOID:12603 | G | intron | GWASdb_trait |
| 1 | 92608029 | rs2893200 | G | A | rs2893200 | 0.00038 | | | Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) | HPOID:0001370 | DOID:7148 | G | intron | GWASdb_trait |
| 1 | 92608029 | rs2893200 | G | A | rs2893200 | 3.80E-04 | | | Methotrexate clearance (acute lymphoblastic leukemia) | HPOID:0006721 | DOID:9952|DOID:12603 | G | intron | GWASdb_trait |